MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

P Belli, M Costantini, C Malaspina, A Magistrelli… - Clinical radiology, 2006 - Elsevier
AIM: To assess the accuracy of magnetic resonance imaging (MRI) in evaluating residual
disease after neoadjuvant chemotherapy in patients with large breast cancers. MATERIALS …
被引用次数：126 相关文章

MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

P Belli, M Costantini, C Malaspina… - Clinical …, 2006 - clinicalradiologyonline.net
Aim To assess the accuracy of magnetic resonance imaging (MRI) in evaluating residual
disease after neoadjuvant chemotherapy in patients with large breast cancers. Materials and …

MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

P Belli, M Costantini, C Malaspina, A Magistrelli… - Clinical …, 2006 - inis.iaea.org
[en] Aim: To assess the accuracy of magnetic resonance imaging (MRI) in evaluating
residual disease after neoadjuvant chemotherapy in patients with large breast cancers …

MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

P Belli, M Costantini, C Malaspina… - Clinical …, 2006 - pubmed.ncbi.nlm.nih.gov
Aim To assess the accuracy of magnetic resonance imaging (MRI) in evaluating residual
disease after neoadjuvant chemotherapy in patients with large breast cancers. Materials and …

[引用][C] MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

P BELLI - Clin Radiol., 2006 - cir.nii.ac.jp

MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

P Belli, M Costantini, C Malaspina, A Magistrelli… - Clinical Radiology, 2006 - osti.gov
Aim: To assess the accuracy of magnetic resonance imaging (MRI) in evaluating residual
disease after neoadjuvant chemotherapy in patients with large breast cancers. Materials and …

MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

P Belli, M Costantini, C Malaspina, A Magistrelli… - Clinical Radiology, 2006 - infona.pl
To assess the accuracy of magnetic resonance imaging (MRI) in evaluating residual disease
after neoadjuvant chemotherapy in patients with large breast cancers. Forty-five women with …

MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy.

P Belli, M Costantini, C Malaspina, A Magistrelli… - Clinical …, 2006 - europepmc.org
Aim To assess the accuracy of magnetic resonance imaging (MRI) in evaluating residual
disease after neoadjuvant chemotherapy in patients with large breast cancers. Materials and …

[引用][C] MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

P BELLI, M COSTANTINI, C MALASPINA… - Clinical …, 2006 - pascal-francis.inist.fr
MRI accuracy in residual disease evaluation in breast cancer patients treated with
neoadjuvant chemotherapy CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[引用][C] MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

P BELLI - Clin Radiol., 2006 - cir.nii.ac.jp